• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Johns Hopkins RheumTV

Show Search
Hide Search
  • About
  • Diseases
    • Ankylosing Spondylitis
    • Inclusion Body Myositis
    • Gout
    • Inflammatory Arthritis
    • Lupus
    • Lyme Disease
    • Myositis
    • Polymyositis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Scleroderma
    • Sjögren’s Syndrome
    • Vasculitis
  • Topics
    • Disease Information
    • Exercise Tips
    • Lifestyle Tips
    • Medication Education
    • Patient Education
    • Biologic Medication Education
    • Corticosteroids
  • Contact Us
Home / RheumTV / COVID-19 (Coronavirus) Information for Rheumatic Disease Patients

COVID-19 (Coronavirus) Information for Rheumatic Disease Patients

COVID-19, or coronavirus, is affecting all of us. However, people who are immunocompromised due to medications for their rheumatic diseases may be considered “high risk” for infection.

In this video, Laura Hummers, the clinical director of Johns Hopkins Rheumatology, and Vicky Ruffing, Director of Patient Education, answer some of your most pressing questions about how this outbreak could affect rheumatic patients.

The information in this video is current as of March 16, 2020. Patients should stay in touch with their health care providers and updated information from the Centers for Disease Control.

In This Video

Primary Sidebar

Related Content

  1. Lyme Disease Prognosis Lyme Disease Prognosis
  2. Rheumatoid Arthritis Signs & Symptoms
  3. Diagnosing Lyme Disease Lyme Disease Diagnosis

Johns Hopkins Medicine

© 2025 Johns Hopkins Rheumatology
Patient Privacy